Evidence map›Paper›PMID 28028366›Full record

ArticleWorld journal of gastroenterology2016

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.

Wei Jiang, Mei-Hua Guo, Xin Hai

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Lycopene: A Potent Antioxidant with Multiple Health Benefits.Journal of nutrition and metabolism · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Total Flavonoids fromFoods (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Potential hepatoprotective effects ofFrontiers in pharmacology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wei JiangWei Jiang, Mei-Hua Guo, Xin Hai, Pharmacy Department, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Mei-Hua GuoWei Jiang, Mei-Hua Guo, Xin Hai, Pharmacy Department, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Xin HaiWei Jiang, Mei-Hua Guo, Xin Hai, Pharmacy Department, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the hepatoprotective effect of lycopene (Ly) on non-alcoholic fatty liver disease (NAFLD) in rat.

methodsA rat model of NAFLD was first established by feeding a high-fat diet for 14 wk. Sixty-five rats were randomly divided into normal group, model group and Ly treatment groups. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TG), total cholesterol (TC) in serum and low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), free fatty acid (FFA), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH) in liver tissue were evaluated, respectively. While the hepatoprotective effect was also confirmed by histopathological analysis, the expression levels of TNF-α and cytochrome P

resultsA significant decrease was observed in the levels of serum AST (2.07-fold), ALT (2.95-fold), and the blood lipid TG (2.34-fold) and TC (1.66-fold) in the dose of 20 mg/kg Ly-treated rats (

conclusionThis study suggests that Ly has a protective effect on NAFLD, down-regulates expression of TNF-α, and that CYP2E1 may be one of the action mechanisms for Ly.

Indexed as

Diet, High-FatAlanine TransaminaseAnimalsAntioxidantsAspartate AminotransferasesCarotenoidsCholesterol, HDLCholesterol, LDLCytochrome P-450 CYP2E1Fatty Acids, NonesterifiedGlutathioneLipid PeroxidationLiverLycopeneMaleMalondialdehydeAlanine TransaminaseAntioxidantsAspartate AminotransferasesCarotenoidsCholesterol, HDLCholesterol, LDLCytochrome P-450 CYP2E1Fatty Acids, NonesterifiedGlutathioneLycopeneMalondialdehydeProtective AgentsSuperoxide DismutaseTriglyceridesTumor Necrosis Factor-alphaAntioxidantCytochrome P450 2E1HepatoprotectiveLycopeneNon-alcoholic fatty liver

Identifiers

PMID28028366
PMCPMC5155177
OpenAlexW2565142131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.